Expertise in
2
conditions

Werner Scheithauer

Vienna, AT 
Expertise in
2
conditions
Vienna, AT 

Overview

Werner Scheithauer practices practicing medicine in Vienna, Austria.

Mr. Scheithauer is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Agranulocytosis, and Renal Hypomagnesemia Type 2.

He is actively involved in clinical research, co-authoring 62 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study to Assess Efficacy and Safety of Capecitabine and Irinotecan Plus Bevacizumab Followed by Capecitabine and Oxaliplatin Plus Bevacizumab or the Reverse Sequence in Patients With Metastatic Colorectal Cancer
A Phase II Study to Assess Efficacy and Safety of Capecitabine and Irinotecan Plus Bevacizumab Followed by Capecitabine and Oxaliplatin Plus Bevacizumab or the Reverse Sequence in Patients With Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment
Evaluation of an Immunomodulatory Maintenance Treatment in Patients With Metastatic Colorectal Cancer With Tumor Reduction During Induction Treatment
Enrollment Status: Unknown
Publish Date: September 10, 2019
Intervention Type: Drug, Other
Study Drug: MGN1703
Study Phase: Phase 3
View 1 Less Clinical Trial

62 Total Publications

Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 13, 2025

Frequently Asked Questions about Werner Scheithauer

Is Werner Scheithauer a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Werner Scheithauer is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Werner Scheithauer participate in research or clinical trials?

Yes. Werner Scheithauer has published 62 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Werner Scheithauer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Scheithauer's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile